Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Substance-Related Disorders × Acceptance and Commitment Therapy × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Fatigue 2 Caregiver Burden 2 Substance-Related Disorders 1 Smoking Cessation 1 Malignant Hepatobiliary Neoplasm 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1

Interventions

Ultrasonic Waves 1 Therapeutics 1 Focus Groups 1 Ethanol 1 Educational Status 1 Dosage Forms 1 Cognitive Behavioral Therapy 1 Behavior Therapy 1 Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05643027 2025-12-05

ACTION

Dana-Farber Cancer Institute

Phase NA Recruiting

Neoplasms, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡